Tariffs and geopolitical factors lead to flat manufacturing forecast for 2025

Alice Gens Chief Operating Officer/CFO - New Jersey Business & Industry Association
Alice Gens Chief Operating Officer/CFO - New Jersey Business & Industry Association
0Comments

The latest report from the Institute of Supply Management (ISM) indicates that manufacturing revenues are expected to remain flat for 2025. This is a significant decrease from the December forecast, which predicted a 4.2% increase. The report attributes this change to trade issues, ongoing inflation concerns, and geopolitical uncertainty.

According to the Spring 2025 ISM Supply Chain Planning Forecast, respondents have become less optimistic compared to six months ago. They now anticipate only a 0.1% increase in manufacturing revenue, a 1.3% decrease in capital expenditures, and capacity utilization at 79.2%. The price of raw materials is projected to rise by 7.5%, while manufacturing employment is expected to see a slight decline of 0.1%.

Out of the 18 manufacturing sectors analyzed, only eight are expected to experience revenue growth: Primary Metals; Miscellaneous Manufacturing; Computer & Electronic Products; Chemical Products; Electrical Equipment, Appliances & Components; Printing & Related Support Activities; Food, Beverage & Tobacco Products; and Transportation Equipment.

In the services industry, there is also a shift in expectations with no overall change anticipated for 2025 revenues compared to the previous forecast of a 3.9% increase made in December 2024. Capital expenditures in this sector are predicted to decrease by 3.3%, with operating capacity levels forecasted at an overall rate of 86.5%.

Nine out of eighteen service industry sectors are projected to see revenue increases: Accommodation & Food Services; Arts, Entertainment & Recreation; Finance & Insurance; Information; Wholesale Trade; Transportation & Warehousing; Health Care & Social Assistance; Professional, Scientific & Technical Services; and Utilities.



Related

Chrissy Buteas President and Chief Executive Officer

HealthCare Institute of New Jersey comments on passage of Patient and Provider Protection Act

Chrissy Buteas of HINJ commented on legislative efforts aimed at lowering patient costs after A-1502 passed committee review. The statement highlighted concerns about pharmacy benefit managers’ roles in drug pricing. HINJ also emphasized its broader mission supporting healthcare innovation.

Michele Siekerka President & CEO

NJBIA recommends changes to Fair Price Protection Act in Assembly testimony

The New Jersey Business & Industry Association has called for amendments to pending legislation on grocery store pricing practices. The group seeks clarity on how technology can support both transparency for consumers and operational improvements for retailers.

Michele Siekerka President & CEO

Trucking groups call for reinstatement of IRS test for worker classification in New Jersey

Two major trucking associations have called on state leaders in New Jersey to restore a federal standard used for classifying workers as employees or freelancers. The groups warn that recent regulatory changes create confusion and could harm both independent contractors and supply chains across the state.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from New Jersey Review.